DIA Biosimilars 2013

Premier Research

Premier Research expands in Salt Lake City and Phoenix

Thursday, February 23, 2012 02:39 PM

CRO Premier Research Group is opening state-of-the-art clinical research facilities in Phoenix, Ariz., and Salt Lake City, Utah, increasing its testing facilities capacity by 50%.
 
“We are excited to be expanding our existing clinical research facilities to accommodate more phase I and outpatient studies,” stated Michael Kuss, vice president, analgesia, Premier Research.

More... »

Cenduit: Now with Patient Reminders

Premier Research names Sean Russell marketing VP

Monday, February 13, 2012 03:53 PM

Premier Research Group has appointed Sean Russell vice president, marketing.

More... »

CRF Health – eCOA Forum

Premier Research names Drouet executive director, Oncology Europe

Monday, January 23, 2012 12:36 PM

Premier Research Group has appointed Etienne Drouet executive director, Oncology Europe. Drouet will play a leading role in the operations, strategic planning and corporate development of Premier Research’s growing portfolio of oncology businesses.

More... »

Susan Stansfield named executive VP, clinical development at Premier Research

Friday, January 13, 2012 12:03 PM

Premier Research Group has named Susan C. Stansfield, Ph.D., its new executive vice president of clinical development.

More... »

Gong joins Premier Research

Wednesday, December 21, 2011 12:32 PM

Premier Research Group has named Hua Gong executive director of medical diagnostics. In this role, Gong will be responsible for overseeing the in vitro diagnostics (IVD) business within the company.

More... »

Biothera names chief medical officer

Monday, November 21, 2011 04:07 PM

Biothera has named Patricia Molloy, M.D., chief medical officer. In this role, Molloy is responsible for the clinical development of Imprime PGG, the company’s immunotherapeutic oncology drug that is currently in multiple clinical trials for colorectal and lung cancer and chronic lymphocytic leukemia.

More... »

Beazeley joins Premier Research Group

Tuesday, September 27, 2011 12:27 PM

Premier Research Group has named Tilly Beazeley senior director, business development covering the United Kingdom and Scandinavia. In this role, Beazeley will be responsible for all of the company’s business development activities in support of strategic growth and development plans for this region.

More... »

Premier Research Groups names VP of human resources

Monday, August 1, 2011 12:44 PM

Premier Research Group has named Mark P. Sneff vice president, human resources. In this role, Sneff will be responsible for the global human resources function and staff in support of Premier Research’s strategic goals.

More... »

Ronald Kershner named VP of biostatistics and data operations at Premier Research Group

Tuesday, May 17, 2011 12:03 PM

Premier Research Group has appointed Ronald Kershner, Ph.D. to the position of vice president, Biostatistics and Data Operations for North America.

More... »

Premier Research re-brands medical device unit

Wednesday, April 20, 2011 11:52 AM

CRO Premier Research has re-branded its medical device business unit to D-TARGET, a Premier Research company.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs